{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:50:16Z","timestamp":1791053416584,"version":"4.1.0"},"reference-count":106,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,1]]},"abstract":"<jats:p content-type=\"fine-print\">P Primitive neuroectodermal tumors (PNETs) are malignant tumors with a high propensity to disseminate throughout the cerebrospinal fluid. Current treatment guidelines are largely determined by clinically based prognostic factors, the most important of which are tumor location and the extent of tumor spread. Although the cure rate for high-risk PNETs has improved, the irreversible sequelae of craniospinal axis radiation treatment in patients who survive have motivated researchers to investigate more fully which patients can safely receive less treatment. The author reviews the literature, describes currently available treatment options for patients with high-risk PNETs, and discusses strategies aimed at improving outcome and refining prognosis that are currently being explored.<\/jats:p>","DOI":"10.3171\/ped.2005.102.1.0044","type":"journal-article","created":{"date-parts":[[2010,8,27]],"date-time":"2010-08-27T06:01:06Z","timestamp":1282888866000},"page":"44-52","source":"Crossref","is-referenced-by-count":10,"title":["Treatment strategies for high-risk medulloblastoma and supratentorial primitive neuroectodermal tumors"],"prefix":"10.3171","volume":"102","author":[{"given":"Regina I.","family":"Jakacki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Pediatr Neurosurg","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000121292","article-title":"Prognostic factors in children with supratentorial (nonpineal) primitive neuroectodermal tumors: a neurosurgical perspective from the Children's Cancer Group.","volume":"22","author":"Albright","year":"1995"},{"key":"b2","series-title":"Neuro-oncology","first-page":"247","article-title":"A Phase I\/II study for newly diagnosed high risk PNET consisting of neoadjuvant chemotherapy (CHT) followed by hyperfractionated radiotherapy (RT): preliminary results of CCG 9931.","volume":"2","author":"Allen","year":"2000"},{"key":"b3","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0360-3016(96)00450-6","article-title":"Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors.","volume":"36","author":"Allen","year":"1996"},{"key":"b4","series-title":"Med Pediatr Oncol","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/mpo.2950120308","article-title":"CNS primitive neuroectodermal tumors of childhood.","volume":"12","author":"Ashwal","year":"1984"},{"key":"b5","series-title":"Arch Neurol Psychiatr","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1001\/archneurpsyc.1925.02200140055002","article-title":"Medulloblastoma cerebelli: a common type of mid-cerebellar glioma of childhood.","volume":"14","author":"Bailey","year":"1925"},{"key":"b6","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3171\/jns.1983.59.3.0418","article-title":"Primary cerebral neuroblastoma. Long-term follow-up review and therapeutic guidelines.","volume":"59","author":"Berger","year":"1983"},{"key":"b7","series-title":"Eur J Cancer","first-page":"1478","article-title":"Metastic medulloblastoma: the experience of the French Cooperative M7 Group.","volume":"30A","author":"Bouffet","year":"1994"},{"key":"b8","series-title":"J Neuropathol Exp Neurol","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/jnen\/59.10.857","article-title":"\u201cLarge cell\/anaplastic\u201d medulloblastomas: a Pediatric Oncology Group Study.","volume":"59","author":"Brown","year":"2000"},{"key":"b9","series-title":"Cancer Genet Cytogenet","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0165-4608(96)00319-6","article-title":"Chromosome arm 17p deletion analysis reveals molecular genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system.","volume":"97","author":"Burnett","year":"1997"},{"key":"b10","series-title":"Radiology","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1148\/93.6.1351","article-title":"An operative staging system and a megavoltage radiotherapeutic technique for cerebellar medulloblastomas.","volume":"93","author":"Chang","year":"1969"},{"key":"b11","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1200\/JCO.1995.13.7.1687","article-title":"Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Childrens Cancer Group randomized trial.","volume":"13","author":"Cohen","year":"1995"},{"key":"b12","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/BF00165520","article-title":"Supratentorial primitive neuroectodermal tumors in children.","volume":"29","author":"Dirks","year":"1996"},{"key":"b13","series-title":"Med Pediatr Oncol","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/mpo.2950250109","article-title":"Lack of efficacy of postoperative chemotherapy and delayed radiation in very young children with pineoblastoma. Pediatric Oncology Group.","volume":"25","author":"Duffner","year":"1995"},{"key":"b14","series-title":"New Engl J Med","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1056\/NEJM199306173282401","article-title":"Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors.","volume":"328","author":"Duffner","year":"1993"},{"key":"b15","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/cncr.10189","article-title":"Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study.","volume":"94","author":"Eberhart","year":"2002"},{"key":"b16","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3171\/jns.1990.72.4.0572","article-title":"The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.","volume":"72","author":"Evans","year":"1990"},{"key":"b17","series-title":"Neurol Clin","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0733-8619(18)31013-2","article-title":"Rational approaches to the che motherapy of medulloblastoma.","volume":"3","author":"Friedman","year":"1985"},{"key":"b18","series-title":"J Neurooncol","first-page":"23","article-title":"Primitive neuroectodermal tumours of the cerebrum. Pathology and treatment.","volume":"3","author":"Gaffney","year":"1985"},{"key":"b19","series-title":"Pediatr Neurosurg","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000121121","article-title":"Medulloblastoma with brain stem involvement: the impact of gross total resection on outcome.","volume":"25","author":"Gajjar","year":"1996"},{"key":"b20","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1200\/JCO.1994.12.8.1607","article-title":"Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.","volume":"12","author":"Geyer","year":"1994"},{"key":"b21","series-title":"Br J Cancer","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1054\/bjoc.2001.1987","article-title":"Clinical and molecular stratification of disease risk in medulloblastoma.","volume":"85","author":"Gilbertson","year":"2001"},{"key":"b22","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1200\/JCO.2000.18.5.1027","article-title":"TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors.","volume":"18","author":"Grotzer","year":"2000"},{"key":"b23","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/nm904","article-title":"BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect.","volume":"9","author":"Hallahan","year":"2003"},{"key":"b24","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1200\/JCO.1995.13.6.1377","article-title":"Survival and prognostic factors following radiation and\/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the Childrens Cancer Group.","volume":"13","author":"Jakacki","year":"1995"},{"key":"b25","series-title":"Ann Neurol","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ana.410390410","article-title":"Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors.","volume":"39","author":"Janss","year":"1996"},{"key":"b26","series-title":"Histologic Typing of Tumors of the Central Nervous System","year":"1993"},{"key":"b27","series-title":"\u2018Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0360-3016(99)00369-7","article-title":"Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT 91.","volume":"46","author":"Kortmann","year":"2000"},{"key":"b28","series-title":"Neurooncol","first-page":"50","article-title":"Preradiation (PRE-RT-C) versus postradiation (POST-RT-C) chemotherapy in standard-risk medulloblastoma (SRMB): final results of the HIT'91 trial.","volume":"5","author":"Kuhl","year":"2003"},{"key":"b29","series-title":"Klin Pediatr","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1055\/s-2008-1043883","article-title":"Preradiation chemotherapy of children and young adults with malignant brain tumors: results of the German pilot trial HIT \u201888\/\u201989.","volume":"210","author":"Kuhl","year":"1998"},{"key":"b30","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3171\/jns.2001.95.1.0082","article-title":"Large cell\/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features.","volume":"95","author":"Leonard","year":"2001"},{"key":"b31","series-title":"Nat Genet","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/ng731","article-title":"Expression profiling of medulloblastoma: PDGFRA and the RAS\/MAPK pathway as therapeutic targets for metastatic disease.","volume":"29","author":"MacDonald","year":"2001"},{"key":"b32","series-title":"Med Pediatr Oncol","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/mpo.1277","article-title":"Supratentorial embryonal tumors in children under 5 years of age: an SFOP study of treatment with postoperative chemotherapy alone.","volume":"38","author":"Marec-Berard","year":"2002"},{"key":"b33","series-title":"Med Pediatr Oncol","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/mpo.2950240309","article-title":"Carboplatin in childhood medulloblastoma\/PNET: feasibility of an in vivo sensitivity test in an \u201cupfront\u201d study.","volume":"24","author":"Mastrangelo","year":"1995"},{"key":"b34","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1002\/1097-0142(19931101)72:9<2755::AID-CNCR2820720937>3.0.CO;2-V","article-title":"Preradiation chemotherapy in advanced medulloblastoma: a Pediatric Oncology Group pilot study.","volume":"72","author":"Mosijczuk","year":"1993"},{"key":"b35","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1200\/JCO.1999.17.7.2127","article-title":"Treatment of children with medulloblastomas with reduced-dose craniospinal radition therapy and adjuvant chemotherapy: a Children's Cancer Group Study.","volume":"17","author":"Packer","year":"1999"},{"key":"b36","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3171\/jns.1994.81.5.0690","article-title":"Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.","volume":"81","author":"Packer","year":"1994"},{"key":"b37","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/(SICI)1097-0142(19990701)86:1<142::AID-CNCR20>3.0.CO;2-Y","article-title":"Medulloblastoma and supratentorial primitive neuroectodermal tumors: an institutional experience.","volume":"86","author":"Paulino","year":"1999"},{"key":"b38","series-title":"Nature","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/415436a","article-title":"Prediction of central nervous system embryonal tumour outcome based on gene expression.","volume":"415","author":"Pomeroy","year":"2002"},{"key":"b39","series-title":"Pediatr Neurosurg","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000121120","article-title":"Treatment of high-risk meduloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.","volume":"25","author":"Prados","year":"1996"},{"key":"b40","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<2189::AID-CNCR27>3.0.CO;2-G","article-title":"Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy.","volume":"88","author":"Reddy","year":"2000"},{"key":"b41","series-title":"J Neuropathol Exp Neurol","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005072-198301000-00001","article-title":"The cerebral medulloblastoma and its relationship to primitive neuroectodermal tumors.","volume":"42","author":"Rorke","year":"1983"},{"key":"b42","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<331::AID-CNCR18>3.0.CO;2-#","article-title":"Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors.","volume":"86","author":"Russo","year":"1999"},{"key":"b43","series-title":"Proc Natl Acad Sci USA","doi-asserted-by":"publisher","first-page":"12867","DOI":"10.1073\/pnas.91.26.12867","article-title":"Expression of the neutrotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma.","volume":"91","author":"Segal","year":"1994"},{"key":"b44","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0360-3016(91)90094-K","article-title":"Interaction of platinum drugs with clinically relevant x-ray doses in mammalian cells: a comparison of cisplatin, carboplatin, iproplatin, and tetraplatin.","volume":"20","author":"Skov","year":"1991"},{"key":"b45","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1200\/JCO.2001.19.10.2696","article-title":"Feasibility of four consecutive high-dose chemotherapy cycles with stem cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.","volume":"19","author":"Strother","year":"2001"},{"key":"b46","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0360-3016(82)90517-X","article-title":"Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships.","volume":"8","author":"Thames","year":"1982"},{"key":"b47","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1200\/JCO.2002.20.3.842","article-title":"Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88\/89 and 91.","volume":"20","author":"Timmermann","year":"2002"},{"key":"b48","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/BF00163707","article-title":"Cerebral primitive neuroectodomeral tumors in childhood.","volume":"6","author":"Tomita","year":"1988"},{"key":"b49","series-title":"Br J Radiol","first-page":"1","article-title":"Kinetic considerations in the choice of treatment schedules for neuraxis radtiotherapy.","volume":"66","author":"Wheldon","year":"1993"},{"key":"b50","series-title":"Childs Nerv Syst","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s003810050418","article-title":"Supratentorial primitive neuroectodermal tumor in children: clinical features, treatment outcome and prognostic factors.","volume":"15","author":"Yang","year":"1999"},{"key":"b51","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0360-3016(97)00010-2","article-title":"The effect of M-stage on patterns of failure in posterior fossa primitive neuroectodermal tumors treated on CCG-921: a phase III study in a high-risk patient population.","volume":"38","author":"Yao","year":"1997"},{"key":"b52","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S0360-3016(01)02044-2","article-title":"Response to pre-radiation chemotherapy is predictive of improved survival in high risk medulloblastoma: results from Pediatric Oncology Group (POG 9031).","volume":"51","author":"Yock","year":"2001"},{"key":"b53","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1200\/JCO.1999.17.3.832","article-title":"Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.","volume":"17","author":"Zeltzer","year":"1999"},{"key":"b1","series-title":"Pediatr Neurosurg","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000121292","article-title":"Prognostic factors in children with supratentorial (nonpineal) primitive neuroectodermal tumors: a neurosurgical perspective from the Children's Cancer Group.","volume":"22","author":"Albright","year":"1995"},{"key":"b2","series-title":"Neuro-oncology","first-page":"247","article-title":"A Phase I\/II study for newly diagnosed high risk PNET consisting of neoadjuvant chemotherapy (CHT) followed by hyperfractionated radiotherapy (RT): preliminary results of CCG 9931.","volume":"2","author":"Allen","year":"2000"},{"key":"b3","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0360-3016(96)00450-6","article-title":"Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors.","volume":"36","author":"Allen","year":"1996"},{"key":"b4","series-title":"Med Pediatr Oncol","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/mpo.2950120308","article-title":"CNS primitive neuroectodermal tumors of childhood.","volume":"12","author":"Ashwal","year":"1984"},{"key":"b5","series-title":"Arch Neurol Psychiatr","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1001\/archneurpsyc.1925.02200140055002","article-title":"Medulloblastoma cerebelli: a common type of mid-cerebellar glioma of childhood.","volume":"14","author":"Bailey","year":"1925"},{"key":"b6","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3171\/jns.1983.59.3.0418","article-title":"Primary cerebral neuroblastoma. Long-term follow-up review and therapeutic guidelines.","volume":"59","author":"Berger","year":"1983"},{"key":"b7","series-title":"Eur J Cancer","first-page":"1478","article-title":"Metastic medulloblastoma: the experience of the French Cooperative M7 Group.","volume":"30A","author":"Bouffet","year":"1994"},{"key":"b8","series-title":"J Neuropathol Exp Neurol","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/jnen\/59.10.857","article-title":"\u201cLarge cell\/anaplastic\u201d medulloblastomas: a Pediatric Oncology Group Study.","volume":"59","author":"Brown","year":"2000"},{"key":"b9","series-title":"Cancer Genet Cytogenet","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0165-4608(96)00319-6","article-title":"Chromosome arm 17p deletion analysis reveals molecular genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system.","volume":"97","author":"Burnett","year":"1997"},{"key":"b10","series-title":"Radiology","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1148\/93.6.1351","article-title":"An operative staging system and a megavoltage radiotherapeutic technique for cerebellar medulloblastomas.","volume":"93","author":"Chang","year":"1969"},{"key":"b11","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1200\/JCO.1995.13.7.1687","article-title":"Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Childrens Cancer Group randomized trial.","volume":"13","author":"Cohen","year":"1995"},{"key":"b12","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/BF00165520","article-title":"Supratentorial primitive neuroectodermal tumors in children.","volume":"29","author":"Dirks","year":"1996"},{"key":"b13","series-title":"Med Pediatr Oncol","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/mpo.2950250109","article-title":"Lack of efficacy of postoperative chemotherapy and delayed radiation in very young children with pineoblastoma. Pediatric Oncology Group.","volume":"25","author":"Duffner","year":"1995"},{"key":"b14","series-title":"New Engl J Med","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1056\/NEJM199306173282401","article-title":"Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors.","volume":"328","author":"Duffner","year":"1993"},{"key":"b15","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/cncr.10189","article-title":"Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study.","volume":"94","author":"Eberhart","year":"2002"},{"key":"b16","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3171\/jns.1990.72.4.0572","article-title":"The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.","volume":"72","author":"Evans","year":"1990"},{"key":"b17","series-title":"Neurol Clin","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0733-8619(18)31013-2","article-title":"Rational approaches to the che motherapy of medulloblastoma.","volume":"3","author":"Friedman","year":"1985"},{"key":"b18","series-title":"J Neurooncol","first-page":"23","article-title":"Primitive neuroectodermal tumours of the cerebrum. Pathology and treatment.","volume":"3","author":"Gaffney","year":"1985"},{"key":"b19","series-title":"Pediatr Neurosurg","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000121121","article-title":"Medulloblastoma with brain stem involvement: the impact of gross total resection on outcome.","volume":"25","author":"Gajjar","year":"1996"},{"key":"b20","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1200\/JCO.1994.12.8.1607","article-title":"Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.","volume":"12","author":"Geyer","year":"1994"},{"key":"b21","series-title":"Br J Cancer","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1054\/bjoc.2001.1987","article-title":"Clinical and molecular stratification of disease risk in medulloblastoma.","volume":"85","author":"Gilbertson","year":"2001"},{"key":"b22","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1200\/JCO.2000.18.5.1027","article-title":"TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors.","volume":"18","author":"Grotzer","year":"2000"},{"key":"b23","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/nm904","article-title":"BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect.","volume":"9","author":"Hallahan","year":"2003"},{"key":"b24","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1200\/JCO.1995.13.6.1377","article-title":"Survival and prognostic factors following radiation and\/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the Childrens Cancer Group.","volume":"13","author":"Jakacki","year":"1995"},{"key":"b25","series-title":"Ann Neurol","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ana.410390410","article-title":"Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors.","volume":"39","author":"Janss","year":"1996"},{"key":"b26","series-title":"Histologic Typing of Tumors of the Central Nervous System","year":"1993"},{"key":"b27","series-title":"\u2018Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0360-3016(99)00369-7","article-title":"Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT 91.","volume":"46","author":"Kortmann","year":"2000"},{"key":"b28","series-title":"Neurooncol","first-page":"50","article-title":"Preradiation (PRE-RT-C) versus postradiation (POST-RT-C) chemotherapy in standard-risk medulloblastoma (SRMB): final results of the HIT'91 trial.","volume":"5","author":"Kuhl","year":"2003"},{"key":"b29","series-title":"Klin Pediatr","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1055\/s-2008-1043883","article-title":"Preradiation chemotherapy of children and young adults with malignant brain tumors: results of the German pilot trial HIT \u201888\/\u201989.","volume":"210","author":"Kuhl","year":"1998"},{"key":"b30","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3171\/jns.2001.95.1.0082","article-title":"Large cell\/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features.","volume":"95","author":"Leonard","year":"2001"},{"key":"b31","series-title":"Nat Genet","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/ng731","article-title":"Expression profiling of medulloblastoma: PDGFRA and the RAS\/MAPK pathway as therapeutic targets for metastatic disease.","volume":"29","author":"MacDonald","year":"2001"},{"key":"b32","series-title":"Med Pediatr Oncol","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/mpo.1277","article-title":"Supratentorial embryonal tumors in children under 5 years of age: an SFOP study of treatment with postoperative chemotherapy alone.","volume":"38","author":"Marec-Berard","year":"2002"},{"key":"b33","series-title":"Med Pediatr Oncol","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/mpo.2950240309","article-title":"Carboplatin in childhood medulloblastoma\/PNET: feasibility of an in vivo sensitivity test in an \u201cupfront\u201d study.","volume":"24","author":"Mastrangelo","year":"1995"},{"key":"b34","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1002\/1097-0142(19931101)72:9<2755::AID-CNCR2820720937>3.0.CO;2-V","article-title":"Preradiation chemotherapy in advanced medulloblastoma: a Pediatric Oncology Group pilot study.","volume":"72","author":"Mosijczuk","year":"1993"},{"key":"b35","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1200\/JCO.1999.17.7.2127","article-title":"Treatment of children with medulloblastomas with reduced-dose craniospinal radition therapy and adjuvant chemotherapy: a Children's Cancer Group Study.","volume":"17","author":"Packer","year":"1999"},{"key":"b36","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3171\/jns.1994.81.5.0690","article-title":"Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.","volume":"81","author":"Packer","year":"1994"},{"key":"b37","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/(SICI)1097-0142(19990701)86:1<142::AID-CNCR20>3.0.CO;2-Y","article-title":"Medulloblastoma and supratentorial primitive neuroectodermal tumors: an institutional experience.","volume":"86","author":"Paulino","year":"1999"},{"key":"b38","series-title":"Nature","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/415436a","article-title":"Prediction of central nervous system embryonal tumour outcome based on gene expression.","volume":"415","author":"Pomeroy","year":"2002"},{"key":"b39","series-title":"Pediatr Neurosurg","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000121120","article-title":"Treatment of high-risk meduloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.","volume":"25","author":"Prados","year":"1996"},{"key":"b40","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<2189::AID-CNCR27>3.0.CO;2-G","article-title":"Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy.","volume":"88","author":"Reddy","year":"2000"},{"key":"b41","series-title":"J Neuropathol Exp Neurol","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005072-198301000-00001","article-title":"The cerebral medulloblastoma and its relationship to primitive neuroectodermal tumors.","volume":"42","author":"Rorke","year":"1983"},{"key":"b42","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<331::AID-CNCR18>3.0.CO;2-#","article-title":"Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors.","volume":"86","author":"Russo","year":"1999"},{"key":"b43","series-title":"Proc Natl Acad Sci USA","doi-asserted-by":"publisher","first-page":"12867","DOI":"10.1073\/pnas.91.26.12867","article-title":"Expression of the neutrotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma.","volume":"91","author":"Segal","year":"1994"},{"key":"b44","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0360-3016(91)90094-K","article-title":"Interaction of platinum drugs with clinically relevant x-ray doses in mammalian cells: a comparison of cisplatin, carboplatin, iproplatin, and tetraplatin.","volume":"20","author":"Skov","year":"1991"},{"key":"b45","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1200\/JCO.2001.19.10.2696","article-title":"Feasibility of four consecutive high-dose chemotherapy cycles with stem cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.","volume":"19","author":"Strother","year":"2001"},{"key":"b46","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0360-3016(82)90517-X","article-title":"Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships.","volume":"8","author":"Thames","year":"1982"},{"key":"b47","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1200\/JCO.2002.20.3.842","article-title":"Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88\/89 and 91.","volume":"20","author":"Timmermann","year":"2002"},{"key":"b48","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/BF00163707","article-title":"Cerebral primitive neuroectodomeral tumors in childhood.","volume":"6","author":"Tomita","year":"1988"},{"key":"b49","series-title":"Br J Radiol","first-page":"1","article-title":"Kinetic considerations in the choice of treatment schedules for neuraxis radtiotherapy.","volume":"66","author":"Wheldon","year":"1993"},{"key":"b50","series-title":"Childs Nerv Syst","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s003810050418","article-title":"Supratentorial primitive neuroectodermal tumor in children: clinical features, treatment outcome and prognostic factors.","volume":"15","author":"Yang","year":"1999"},{"key":"b51","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0360-3016(97)00010-2","article-title":"The effect of M-stage on patterns of failure in posterior fossa primitive neuroectodermal tumors treated on CCG-921: a phase III study in a high-risk patient population.","volume":"38","author":"Yao","year":"1997"},{"key":"b52","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S0360-3016(01)02044-2","article-title":"Response to pre-radiation chemotherapy is predictive of improved survival in high risk medulloblastoma: results from Pediatric Oncology Group (POG 9031).","volume":"51","author":"Yock","year":"2001"},{"key":"b53","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1200\/JCO.1999.17.3.832","article-title":"Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.","volume":"17","author":"Zeltzer","year":"1999"}],"container-title":["Journal of Neurosurgery: Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/102\/1\/article-p44.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/102\/1\/article-p44.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/102\/1\/article-p44.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T10:19:03Z","timestamp":1782209943000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/102\/1\/article-p44.xml"}},"subtitle":["Review of the literature"],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":106,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3171\/ped.2005.102.1.0044","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}